Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
FEMY is expected to report earnings to fall ∞% to -112 cents per share on August 12
Q2'26
Est.
$-1.13
Q1'26
Beat
by $1.80
Q4'25
Beat
by $0.03
Q3'25
Beat
by $0.03
Q2'25
Est.
$-0.16
The last earnings report on May 08 showed earnings per share of 0 cents, beating the estimate of -179 cents. With 8.93K shares outstanding, the current market capitalization sits at 11.86M.